Translating R&D Into COVID-19 Kits: DxD Hub and Local Medtech Firms Ramp Up Singapore’s Testing Capability
A year has passed since the first case of COVID-19 was reported in Singapore. Ensuring a strong testing capability continues to be one of the nation’s key strategies to contain the spread of the stealthy virus, as large-scale testing allows for the early detection and isolation of cases before they infect others.
From Lab to Market: Putting Diagnostics Innovations on the Fast Track
The Diagnostics Development (DxD) Hub accelerates technology translation from lab to market, to improve healthcare and develop a robust diagnostic devices ecosystem in Singapore.
COVID-19 Vaccines, Immunity & Diagnostics
As excitement soars over pending COVID-19 vaccination programmes in 2021, it is timely to know how an effective vaccine works in producing virus neutralizing antibodies in recipients that generates immunity, and how serology monitoring can measure herd immunity.
PUBLIC-PRIVATE COLLABORATION LEADS TO FINGER-PRICK ANTIBODY TEST KIT FOR COVID-19 THAT DELIVERS RESULTS IN 15 MINUTES
A test kit that can accurately identify SARS-CoV-2 antibodies in 15 minutes and employs a lateral flow format, similar to those used in home pregnancy tests, has been co-developed between A*STAR and diagnostics company MP Biomedicals.
A*STAR & PARTNERS ROLL OUT RESOLUTE 2.0 TEST AND AUTOMATED LAB SYSTEM RAVE THAT UPS TEST DELIVERY THROUGHPUT BY FOUR TIMES
DSO National Laboratories and A*STAR's Diagnostics Development (DxD) Hub have jointly developed RESOLUTE 2.0, a breakthrough Direct-Polymerase Chain Reaction (PCR) diagnostic test kit for COVID-19. This initiative was part of a strategic partnership between DSO and A*STAR that was inked earlier this year to tighten the defence-civilian research nexus.
LUCENCE, A*STAR SHARE STUDY DATA SHOWING SAFER™ SAMPLE SALIVA COLLECTION KIT FOR COVID-19 INACTIVATES COLLECTED VIRUS
SAFER™ Sample Kit offers accessible, non-invasive, and safe sample collection via saliva to enable cost-effective mass testing; Proprietary reagent inactivates virus in sample, while keeping sample stable at room temperature for up to one week
